Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | |
|---|---|---|---|
| Total revenue | 12.57%4.98B | 13.86%4.42B | 3.88B |
| Cost of revenue | 1.72%2.31B | 16.38%2.27B | 1.95B |
| Gross profit | 24.01%2.67B | 11.32%2.15B | 1.93B |
| Operating expense | -11.64%1.18B | 13.81%1.33B | 1.17B |
| Operating profit | 81.68%1.49B | 7.52%822.69M | 765.14M |
| Net non-operating interest income (expenses) | 312.14%664K | 34.11%-313K | -475K |
| Non-operating interest income | 649.23%974K | 32.65%130K | --98K |
| Non-operating interest expense | -30.02%310K | -22.69%443K | --573K |
| Net investment income | -103.32%-7K | -45.34%211K | 386K |
| Gain(Loss) on financial instruments designated as cash flow hedges | |||
| Gain(Loss) on derecognition of available-for-sale financial assets | |||
| Income from associates and other participating interests | |||
| Special income (charges) | 0 | -300.15M | |
| Less:Other special charges | ---- | ---- | --300.15M |
| Other non-operating income (expenses) | -1,288.82%-16.91M | -37.66%1.42M | 2.28M |
| Income before tax | 79.42%1.48B | 76.38%824.01M | 467.18M |
| Income tax | 86.41%460.32M | 77.54%246.94M | 139.09M |
| Net income | 76.43%1.02B | 75.89%577.07M | 328.09M |
| Net income continuous operations | 76.43%1.02B | 75.89%577.08M | --328.09M |
| Noncontrolling interests | 55.76%3.29M | 123.17%2.11M | 945K |
| Net income attributable to the company | 76.50%1.01B | 75.75%574.96M | 327.14M |
| Preferred stock dividends | |||
| Other under preferred stock dividend | 0 | 0 | 0 |
| Net income attributable to common stockholders | 76.50%1.01B | 75.75%574.96M | 327.14M |
| Gross dividend payment | |||
| Basic earnings per share | 75.84%26.96 | 75.75%15.3324 | 8.7238 |
| Diluted earnings per share | 75.84%26.96 | 78.10%15.3324 | 8.609 |
| Dividend per share | 22 | ||
| Currency Unit | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |